Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heme Malignancy”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Testing effectiveness (Phase 2)WithdrawnNCT02765997
What this trial is testing

StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+1 more
Masonic Cancer Center, University of Minnesota
Not applicableStudy completedNCT03778606
What this trial is testing

Oligosaccharide for Cdiff(+) Heme-onc Patients

Who this might be right for
Clostridium DifficileHematologic Diseases
Medical College of Wisconsin 8
Testing effectiveness (Phase 2)Looking for participantsNCT05735717
What this trial is testing

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaRemission+19 more
Masonic Cancer Center, University of Minnesota 70
Not applicableStudy completedNCT04195438
What this trial is testing

Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Who this might be right for
Liver Cancer
University of Maryland, Baltimore 25
Testing effectiveness (Phase 2)Looking for participantsNCT07214688
What this trial is testing

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

Who this might be right for
Allogeneic Stem Cell Transplant Recipient
Hackensack Meridian Health 209
Testing effectiveness (Phase 2)Looking for participantsNCT03314974
What this trial is testing

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+25 more
Masonic Cancer Center, University of Minnesota 300
Not applicableLooking for participantsNCT05556928
What this trial is testing

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

Who this might be right for
Multiple MyelomaAmyloidosisPlasma Cell Leukemia
University of Alabama at Birmingham 5,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT03642626
What this trial is testing

MT2017-45: CAR-T Cell Therapy for Heme Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaLarge B-cell Lymphoma
Masonic Cancer Center, University of Minnesota 150
Not applicableLooking for participantsNCT06681818
What this trial is testing

Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Who this might be right for
Liver Cancer AdultLiver Regeneration
Englewood Hospital and Medical Center 125
Not applicableLooking for participantsNCT06999954
What this trial is testing

Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform

Who this might be right for
Shwachman-Diamond SyndromeSDSIBMF+24 more
Shwachman-Diamond Syndrome Alliance Inc 8,000
Not applicableEnded earlyNCT03955276
What this trial is testing

An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme)

Who this might be right for
Hematologic Cancer
University of California, San Diego 13
Not applicableLooking for participantsNCT06487247
What this trial is testing

HEME Home Transfusion Program

Who this might be right for
LeukemiaMyelomaMyelodysplastic Syndromes+3 more
Dana-Farber Cancer Institute 700
Not applicableStudy completedNCT04690205
What this trial is testing

Hospital at Home at EOL in Heme Malignancies

Who this might be right for
Hematologic Malignancy
Massachusetts General Hospital 72
Testing effectiveness (Phase 2)Ended earlyNCT02991898
What this trial is testing

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more
Masonic Cancer Center, University of Minnesota 3
Not applicableStudy completedNCT05509439
What this trial is testing

Home Transfusion for HEME

Who this might be right for
Hematologic Malignancy
Dana-Farber Cancer Institute 10
Early research (Phase 1)Study completedNCT00477542
What this trial is testing

A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT

Who this might be right for
Hematologic Malignancies
Indiana University School of Medicine 18